eJHaem
(Feb 2022)
Leg‐type form of idiopathic multicentric Castleman disease associated with severe lower extremity chronic venous/lymphatic disease
Thomas Ballul,
Nabil Belfeki,
Adèle deMasson,
Véronique Meignin,
Paul‐Louis Woerther,
Antoine Martin,
Elsa Poullot,
Alain Wargnier,
Jehane Fadlallah,
Margaux Garzaro,
Marion Malphettes,
Claire Fieschi,
Lucas Maisonobe,
Hayat Bensekhri,
Hélène Guillot,
Rémi Bertinchamp,
Marie Jachiet,
Justine Poirot,
Lionel Galicier,
Eric Oksenhendler,
David Boutboul
Affiliations
Thomas Ballul
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Nabil Belfeki
Internal Medicine Department Centre hospitalier de Melun Melun France
Adèle deMasson
Dermatology Department Université de Paris Paris France
Véronique Meignin
Pathology Department Hôpital Saint Louis Université de Paris Paris France
Paul‐Louis Woerther
Bacteriology and Virology Department Hôpital Henri Mondor Créteil France
Antoine Martin
Pathology Department Hôpital Avicenne Université Sorbonne Paris Nord Bobigny France
Elsa Poullot
Pathology Department Hôpital Henri Mondor Université Paris‐Est Créteil Créteil France
Alain Wargnier
Bacteriology Department Hôpital Saint Louis Université de Paris Paris France
Jehane Fadlallah
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Margaux Garzaro
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Marion Malphettes
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Claire Fieschi
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Lucas Maisonobe
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Hayat Bensekhri
Internal Medicine Department Groupe Hospitalier Nord Essonne Longjumeau France
Hélène Guillot
Internal Medicine Department Hôpital Robert Ballanger Université Sorbonne Paris Nord Aulnay‐Sous‐Bois France
Rémi Bertinchamp
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Marie Jachiet
Dermatology Department Université de Paris Paris France
Justine Poirot
INSERM U976 HIPI, Hôpital Saint Louis Université de Paris Paris France
Lionel Galicier
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
Eric Oksenhendler
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
David Boutboul
Clinical Immunology Department Hôpital Saint Louis, Université de Paris Paris France
DOI
https://doi.org/10.1002/jha2.353
Journal volume & issue
Vol. 3,
no. 1
pp.
175
– 179
Abstract
Read online
Abstract Idiopathic multicentric Castleman disease (iMCD) is a lymphoproliferative disease of unknown etiology. Deciphering mechanisms involved in CD pathogenesis may help improving patients’ care. Six cases of stereotyped sub‐diaphragmatic iMCD affecting lower limb‐draining areas and associated with severe and often ulcerative lower extremity chronic dermatological condition were identified in our cohort. Pathological examination revealed mixed or plasma‐cell type MCD. In three patients, shotgun metagenomics failed to identify any pathogen in involved lymph nodes. Antibiotics had a suspensive effect while rituximab and tocilizumab failed to improve the condition. This novel entity requires a specific approach and exclusion of potentially harmful immunomodulation.
Keywords
WeChat QR code
Close